Drug product for the treatment of acute spinal cord injury, cancer, macular degeneration, and glaucoma
There’s no risk. Start your trial today to see profiles of BioAxone Therapeutique plus 5054 other startups.
The Medtech Pro Platform has Expanded! Request Demo
Replay LSI2021 Emerging Medtech Summit Play Now
New 2021 Forecasts Released New Data
New 2021 Forecasts Released Learn More
Become a Medtech Market ProLearn More